+958.0%
MRNA vs CPB
-13.9%
+971.9%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CPB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | +3.4% | -8.2% | -5.6% |
| 7D | -20.9% | +9.2% | -30.1% | -22.6% |
| 30D | -13.3% | +25.9% | -39.2% | -18.3% |
| 3M | +212.6% | +8.0% | +204.6% | +207.5% |
| 6M | +309.0% | +23.4% | +285.6% | +293.3% |
| YTD | +567.3% | -7.0% | +574.3% | +568.2% |
| 1Y | +689.7% | -16.4% | +706.1% | +709.1% |
| 3Y | +157.4% | -31.5% | +189.0% | +170.9% |
| 5Y | -21.7% | -27.3% | +5.6% | -19.4% |
| All | +958.0% | -13.9% | +971.9% | +1,077.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CPB.
Daily Out/Under-Performance
Portfolio return minus CPB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CPB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CPB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling